Lincoln Pharma wins patent for nasal spray to treat vomiting

Lincoln Pharmaceuticals Limited (LPL) has secured a patent for its novel nasal drug delivery system, which the company  says, helps in arresting or preventing vomiting and nausea.

The new nasal spray system could be particularly of help in chemotherapy-induced vomiting, the Ahmedabad-based company said in a release.

At present, anti-vomiting treatments in India are available in the conventional forms of tablet and injection, which take longer time to bring relief. LPL says its new nasal drug delivery system can get immediate relief.

LPL also claims to be the first company in India to introduce an anti-vomiting treatment in the form of a nasal spray pump. 

The new nasal spray formulation of 'Ondansetron Hydrochloride' molecules serves as an agent that prevents or arrests vomiting.

Clinical tests on the efficacy and tolerability of the drug has proved its ability to prevent vomiting and nausea, the company said.